Search by Drug Name or NDC
NDC 72252-0515-04 Valtoco 7.5 mg/.1mL Details
Valtoco 7.5 mg/.1mL
Valtoco is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Neurelis, Inc. The primary component is DIAZEPAM.
MedlinePlus Drug Summary
Diazepam nasal spray is used for emergency situations to stop cluster seizures (episodes of increased seizure activity) in adults and children 6 years of age and older who are taking other medications to treat epilepsy (seizures). Diazepam is in a class of medications called benzodiazepines. It works by calming abnormal overactivity in the brain.
Related Packages: 72252-0515-04Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Diazepam Nasal Spray
Product Information
| NDC | 72252-0515 |
|---|---|
| Product ID | 72252-515_d4304577-0d16-4b10-bce1-c72f81ab2cbc |
| Associated GPIs | 7210003000C440 |
| GCN Sequence Number | 080632 |
| GCN Sequence Number Description | diazepam SPRAY 15/2 SPRAY NASAL |
| HIC3 | H4A |
| HIC3 Description | ANTICONVULSANT - BENZODIAZEPINE TYPE |
| GCN | 47551 |
| HICL Sequence Number | 001615 |
| HICL Sequence Number Description | DIAZEPAM |
| Brand/Generic | Brand |
| Proprietary Name | Valtoco |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | diazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY |
| Route | NASAL |
| Active Ingredient Strength | 7.5 |
| Active Ingredient Units | mg/.1mL |
| Substance Name | DIAZEPAM |
| Labeler Name | Neurelis, Inc |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA211635 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 72252-0515-04 (72252051504)
| NDC Package Code | 72252-515-04 |
|---|---|
| Billing NDC | 72252051504 |
| Package | 2 BLISTER PACK in 1 CARTON (72252-515-04) / 2 VIAL, SINGLE-DOSE in 1 BLISTER PACK / .1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2020-01-10 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 333.676 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | VALTOCO 15 MG NASAL SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis